By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Irish drug development services firm Icon said this week that it has signed an agreement with Empire Genomics to provide personalized medicine development services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.